We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JACK icon
2251
Jack in the Box
JACK
$299M
$211K ﹤0.01%
4,150
-83,023
-95% -$4.66M
SPMD icon
2252
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.4B
$211K ﹤0.01%
+4,107
New +$212K
DK icon
2253
Delek US
DK
$3.95B
$210K ﹤0.01%
8,500
-26,975
-76% -$746K
RGA icon
2254
Reinsurance Group of America
RGA
$15.7B
$210K ﹤0.01%
+1,024
New +$205K
FA icon
2255
First Advantage
FA
$3.43B
$209K ﹤0.01%
+13,000
New +$209K
SKYY icon
2256
First Trust Cloud Computing ETF
SKYY
$2.78B
$209K ﹤0.01%
+2,186
New +$203K
FNGS icon
2257
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$545M
$209K ﹤0.01%
4,250
-32,513
-88% -$1.46M
FLIC
2258
DELISTED
First of Long Island Corp
FLIC
$209K ﹤0.01%
+20,830
New +$211K
PPA icon
2259
Invesco Aerospace & Defense ETF
PPA
$8.37B
$209K ﹤0.01%
+2,030
New +$208K
SGMO
2260
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$207K ﹤0.01%
576,219
+207,476
+56% +$112K
ANTX icon
2261
AN2 Therapeutics
ANTX
$178M
$207K ﹤0.01%
96,111
+13,613
+17% +$32.4K
FSK icon
2262
FS KKR Capital
FSK
$3.04B
$206K ﹤0.01%
+10,465
New +$206K
BP icon
2263
BP
BP
$109B
$206K ﹤0.01%
5,700
-173,831
-97% -$6.51M
GDS icon
2264
GDS Holdings
GDS
$6.28B
$203K ﹤0.01%
+21,900
New +$177K
DOLE icon
2265
Dole
DOLE
$1.34B
$203K ﹤0.01%
+16,600
New +$202K
OSUR icon
2266
OraSure Technologies
OSUR
$273M
$203K ﹤0.01%
+47,577
New +$242K
CIEN icon
2267
Ciena
CIEN
$53.4B
$202K ﹤0.01%
+4,200
New +$199K
ALTO icon
2268
Alto Ingredients
ALTO
$348M
$202K ﹤0.01%
+139,144
New +$241K
BRC icon
2269
Brady Corp
BRC
$4.54B
$202K ﹤0.01%
3,055
-56,189
-95% -$3.52M
AQST icon
2270
Aquestive Therapeutics
AQST
$468M
$200K ﹤0.01%
+77,016
New +$257K
PARAA
2271
DELISTED
Paramount Global Class A
PARAA
$199K ﹤0.01%
10,800
PPTA
2272
Perpetua Resources
PPTA
$2.28B
$197K ﹤0.01%
+37,977
New +$226K
SFL icon
2273
SFL Corp
SFL
$1.59B
$197K ﹤0.01%
+14,222
New +$193K
UBER icon
2274
CALL
Uber
UBER
$139B
$196K ﹤0.01%
+2,700
New +$188K
PMGMW
2275
CALL
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$196K ﹤0.01%
186,768

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.